MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
*Architects: Neurology, Psychology, Mental Health, CNS, Pain & TBI Companies_Pain
Tris Pharma, Inc
Organization & Developments: Tris Pharma
Parents
Tris Pharma, Inc
Children
2017: VA_65--Tris Pharma, Inc (65IB) V797D-70208 Contract Effective 08/01/2017 to 07/31/2022
2024: Tris Pharma Announces Positive Results from ALLEVIATE-1 Phase 3 Clinical Trial of Cebranopadol, an Investigational First-in-Class Oral Dual-NMR Agonist, for the Treatment of Moderate-to-Severe Acute Pain
2024: Tris Pharma captures FDA nod for non-stimulant ADHD treatment Onyda XR
Jumps
Finance & Acquisition: Tris Pharma
Key People: Tris Pharma